Central Landmark vs USG for IJV Catheterization

Value of Central Landmark Method for Juguler Vein Catheterization Clinical Trial

Official title:

Comparison of Internal Jugular Vein Catheterization Entry Points Determined by Ultrasonography Versus the Central Landmark Guided Method

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01931969
• Other study ID #: CLM vs USG for RIJVC
• Secondary ID: CLMUSGRIJVC
• Status: Active, not recruiting
• Phase: N/A
• First received: August 22, 2013
• Last updated: August 29, 2013
• Start date: December 2012
• Est. completion date: October 2013

Study information

• Verified date: August 2013
• Source: Ankara University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Turkey: Ministry of Health
• Study type: Observational

Clinical Trial Summary

This study is planned to compare right internal jugular vein catheterization entry points determined by ultrasound and the central landmark guided method, and the relationship of each with sternocleidomastoid muscle length and body mass index.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 30
• Est. completion date: October 2013
• Est. primary completion date: September 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

-patients undergoing cardiovascular surgery who needed to have internal jugular vein catheterization aged 18y or older-

Exclusion Criteria:

-previous neck surgery, burns, limited neck movement, diffuse goiter or bleeding problems

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Value of Central Landmark Method for Juguler Vein Catheterization

Locations

Country	Name	City	State
Turkey	Ankara University School Of Medicine	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Ankara University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success rate with the Central Landmark Method		1 mounth	No